Document Detail

Demographic and clinical characteristics of malignant multiple sclerosis.
MedLine Citation:
PMID:  21646626     Owner:  NLM     Status:  In-Data-Review    
OBJECTIVE: Multiple sclerosis (MS) that causes patients to require assistance for ambulation (Expanded Disability Status Scale [EDSS] ≥6) within 5 years from symptom onset is generally termed malignant. Malignant status can be transient (TM) or sustained until year 5 (SM). We studied the incidence, predictors, and demographic and clinical characteristics of malignant MS.
METHODS: Patients with symptom onset in 2002-2005 and 5-year follow-up were selected from the Partners Multiple Sclerosis Center database. Patients with TM were further grouped into TM and SM. The mechanism of reaching EDSS 6 (relapse- vs progression-related) was determined.
RESULTS: A total of 487 patients were included (17 TM, 42 SM). The incidence proportion of ever malignant (EM = SM+TM) was estimated as 12.11% and SM as 8.62%. Patients with older age at onset, male gender, and positive smoking history were more likely to become SM. Compared to nonmalignant patients, the proportion of progressive-onset MS in the SM group was significantly higher, but not different in TM. Within relapsing-onset patients, most of TM, and a smaller proportion of the SM group had a relapse-related as opposed to progression-related mechanism. The final model predictors for EM vs nonmalignant were older age at onset, motor symptoms at onset, and progressive disease onset. Within the malignant patients, predictors of TM vs SM were younger age and brainstem symptoms at onset.
CONCLUSIONS: Over 10% of patients with MS experience a malignant course as defined above. Some demographic and clinical factors are found to predict a malignant outcome. MS in patients who reach a high EDSS based on disease progression is more likely to remain malignant.
T Gholipour; B Healy; N F Baruch; H L Weiner; T Chitnis
Related Documents :
7839926 - The rarity of minimal change disease in nigerian patients with the nephrotic syndrome.
19646346 - Glycosylation of proteinase 3 (pr3) is not required for its reactivity with antineutrop...
2242306 - Renal amyloidosis in juvenile chronic arthritis: evolution after chlorambucil treatment.
8808106 - Prognostic markers in patients with antineutrophil cytoplasmic autoantibody-associated ...
10394476 - An mri study of adolescent patients with either schizophrenia or bipolar disorder as co...
12672196 - Treatment of refractory polymyalgia rheumatica with infliximab: a pilot study.
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  Neurology     Volume:  76     ISSN:  1526-632X     ISO Abbreviation:  Neurology     Publication Date:  2011 Jun 
Date Detail:
Created Date:  2011-06-07     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  0401060     Medline TA:  Neurology     Country:  United States    
Other Details:
Languages:  eng     Pagination:  1996-2001     Citation Subset:  AIM; IM    
Partners Multiple Sclerosis Center, Department of Neurology, Brigham and Women's Hospital, 1 Brookline Place, Suite 602, Brookline, MA 02445
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Common viruses associated with lower pediatric multiple sclerosis risk.
Next Document:  Meta-analysis of the relationship between Parkinson disease and melanoma.